scorecardresearch
Add as a preferred source on Google
Monday, November 24, 2025
TopicDr. Reddy

Topic: Dr. Reddy

Dr Reddy’s sees short-lived boom for Merck’s Covid pills in India

Even as oral Covid pills from Merck, Pfizer are being seen as game changers, generic drugmakers are getting a reality check that there may not be too much money on the table.

Dr Reddy’s inks licensing pact with Eli Lilly for Covid treatment drug Baricitinib

The agreement between the two firms comes days after Eli Lilly signed voluntary licensing agreements with Indian drug companies— Sun Pharma, Cipla and Lupin.

Dr. Reddy’s pushes for immediate right to sell suboxone copies

Indivior Plc’s Suboxone Film is the leading opioid addiction treatment in US.

On Camera

DPDP Act will change how we interact with the internet. Get ready for the consent mails

India does not have a data protection regulator to make good on the DPDP Act’s promise and articulate clear future standards.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

US pilot says his team pulled out of Dubai Air Show after Tejas crash out of respect for IAF pilot

Taylor ‘Fema’ Hiester, commander of USAF F-16 Viper Demo Team, hit out at air show organisers for continuing with the show after Wing Commander Namansh Syal lost his life in the incident.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.